Global burden of acute respiratory infections in children: implications for interventions

Kim Mulholland1

  • 1Centre for International Child Health, Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia. mulhollk@cryptic.rch.unimelb.edu.au

Pediatric Pulmonology
|November 18, 2003
PubMed

Insights

Childhood pneumonia remains a major global health challenge, with current mortality estimates being crude and potentially underestimated. Caution is advised when using these figures to predict vaccine impact on child mortality.

Area of Science:

  • Global Health
  • Pediatrics
  • Epidemiology

Background:

  • Child mortality remains high globally, with significant inequities persisting.
  • Pneumonia is a leading cause of death in children under five, particularly in developing nations.
  • Current estimates of pneumonia's global burden are imprecise due to reliance on verbal autopsies and non-standardized definitions.

Purpose of the Study:

  • To critically evaluate existing estimates of childhood pneumonia burden.
  • To assess the implications of these estimates for predicting the impact of new vaccines.
  • To highlight the need for caution in utilizing current data for public health planning.

Main Methods:

  • Review of existing literature and WHO estimates on childhood pneumonia mortality and morbidity.
  • Analysis of the limitations of verbal autopsy techniques in determining cause of death.
  • Examination of the challenges in standardizing pneumonia case definitions across studies.

Main Results:

  • Global estimates suggest 1.9 million annual child deaths from acute respiratory infections (ARI), primarily pneumonia, though this is likely an underestimate.
  • Existing burden estimates are crude, hindering accurate prediction of mortality reduction from interventions.
  • Variability in pneumonia definitions complicates morbidity burden assessments.

Conclusions:

  • Current estimates of childhood pneumonia burden are inadequate for precise impact assessment of interventions like new vaccines.
  • Further research is needed to refine pneumonia burden estimation methodologies.
  • Careful consideration is required before extrapolating existing data to predict vaccine-driven mortality savings in developing countries.

Related Concept Videos

Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...